JBSS3 after 2Q26: record revenue, a net loss, and what the gap teaches

On 10 August 2026, after the market closed, JBS N.V. published its 2Q26 results (reference date 30 June 2026). Net sales hit a quarterly record of US$ 23.9 billion, up 14% year on year. IFRS adjusted EBITDA fell 18% to US$ 1.43 billion. Net income attributable to JBS swung to a US$ 102 million loss from a US$ 528 million profit in 2Q25 — the first quarterly loss after eleven consecutive profitable quarters. The next session, JBSS32 fell about 4%, according to the financial press. Revenue and profit moving in opposite directions is not a data error. It is the central lesson of a quarter where scale, cattle cycles, poultry oversupply, one-off charges, and shareholder distributions all hit the P&L at once.

What the earnings package actually shows

Figures below follow JBS's 2Q26 earnings release (IFRS, US dollars unless noted):

The headline tension is immediate: top-line growth with a reported bottom-line loss. Before interpreting that as "the business broke," separate three layers — operating profit by geography, non-recurring items below EBITDA, and balance-sheet choices (dividends, debt management) that affect leverage even when cash flow improves.

Revenue grew everywhere; margins did not

JBS is a multi-protein, multi-geography platform. In 2Q26 almost every major unit posted higher sales. Profitability was a different story.

US beef is the clearest example of revenue without earnings. Cutout values stayed historically high on resilient demand, but live cattle prices rose faster than beef prices as herd availability remained tight. Mexican cattle imports were restricted during the quarter (expected to resume gradually from late August). JBS announced closures at Souderton, Pennsylvania (processing) and Memphis, Tennessee (case-ready), absorbing output at other US plants. Management merged Fed Beef, Regional Beef, and Case Ready into a single Beef USA structure to simplify operations. EBITDA was still negative, but less negative than the −US$ 233 million in 2Q25.

Pilgrim's Pride faced a tough comparison: poultry operations posted record results in 2Q25. In 2Q26 firm demand met greater chicken supply — CEO Gilberto Tomazoni cited higher productivity and lower avian-influenza impact in the US and Mexico, which pressured commodity pricing. Adjusted EBITDA fell 38.5% to US$ 503 million; margin compressed 6.3 percentage points to 10.9%. Sequentially, margins improved on productivity and plant upgrades, but the year-on-year gap is large.

Brazil moved the other way. Net sales of US$ 4.59 billion (+28%) were a record for a second quarter, driven by higher prices and volumes in exports (including filling the Chinese beef quota) and in the domestic market (World Cup marketing, key-customer partnerships). Average live cattle cost was about R$ 353 per arroba, up 12% year on year. Even so, adjusted EBITDA of US$ 269 million (+17.8%) was the highest ever for a JBS Brazil second quarter, with a 5.9% margin.

Seara grew sales 18% and held a 14.9% adjusted EBITDA margin — strong in absolute terms, though EBITDA dollars were roughly flat year on year as cost of sales rose faster than revenue. Export volumes of fresh poultry and Middle East sales held up despite a more difficult operating environment; domestically, the company continued pushing value-added and branded products.

From adjusted profit to reported loss

Adjusted net income was US$ 218 million (US$ 0.20 per share) — positive, but down from US$ 0.52 a year ago. The gap to the −US$ 102 million reported loss is where the quarter's "quality" debate lives.

Management highlighted main non-recurring adjustments:

Net financial expenses rose about US$ 319 million year on year in the quarter, according to the earnings call — a separate pressure from operations. Antitrust and debt-tender costs are genuinely non-recurring in the narrow sense, but litigation-related expenses have appeared in prior periods; analysts cited in the press (XP, among others) flagged that such charges can continue to weigh on net income during an unfavourable cattle cycle.

Cash flow improved — for specific reasons

Free cash flow turned positive at US$ 130 million, a US$ 185 million improvement versus cash consumption of US$ 55 million in 2Q25. That sounds healthy. The bridge matters:

• Receivables improved by about US$ 600 million, reflecting more receivables discounting and larger advance payments from Chinese customers on JBS Brazil exports.
• Payables rose about US$ 390 million, mainly from higher cattle prices and increased slaughter volumes in Brazil.
• Offsets included lower adjusted EBITDA (−US$ 324 million), higher net cash interest (+US$ 129 million), and higher capex (+US$ 163 million).

Working-capital timing can flatter a weak EBITDA quarter. Management itself pointed to second-half free cash flow as the test of whether the improvement is structural. Treat 2Q26 FCF as informative, not as a clean run-rate.

Leverage, dividends, and the market reaction

Net leverage ended at 3.1x adjusted EBITDA (LTM), above the company's long-term target range of 2.0x–3.0x and up from 2.3x a year earlier. Interest coverage fell to 5.0x from 7.7x. During the quarter JBS returned US$ 1 billion in dividends — a shareholder-friendly move that still raises leverage when EBITDA is falling. In August the company increased its revolving credit facility to US$ 4.2 billion, cutting all-in cost and taking total liquidity to US$ 7.7 billion; average debt maturity reached 15.3 years at 5.7% average cost.

The roughly 4% drop in JBSS32 on 11 August mapped a familiar read: record revenue did not offset the reported loss, US beef's negative spread, poultry margin compression versus a strong 2Q25 base, leverage above target, and limited near-term catalysts in a pro-cyclical sector. Press coverage noted that adjusted EBITDA of about US$ 1.4 billion was close to consensus even as adjusted net income and reported profit disappointed.

How to use the explorer on this package

1. Open JBSS3. Find the ITR with reference 30/06/2026 and the August 2026 earnings materials.
2. Start with net sales (+14%) and adjusted EBITDA (−18%) — revenue growth and earnings power are not the same object at JBS.
3. Split the platform: US beef (−US$ 78 m EBITDA) vs Brazil (+US$ 269 m, record 2Q) vs Pilgrim's (−38.5% EBITDA YoY) vs Seara (14.9% margin, +18% sales).
4. Read reported net loss (−US$ 102 m) alongside adjusted net income (US$ 218 m) and the bond-tender, antitrust, and finance-expense bridge.
5. Check free cash flow (+US$ 130 m) against the working-capital drivers before treating the quarter as a cash-generation story.
6. For the current quote, use the company page; this article freezes only figures already reported in the release and press.

Limits of this reading

• JBS reports primarily in US dollars under IFRS; US GAAP adjusted figures differ and are also disclosed.
• Segment EBITDA includes company adjustments; biological-asset and leasing reconciliations between IFRS and US GAAP are material.
• Non-recurring labels are management's; antitrust and restructuring items have appeared in earlier periods.
• China beef quota dynamics (temporary exhaustion, expected restart) affect Brazil export volumes forward, not just 2Q26 revenue.
• Working-capital swings from receivable discounting and export prepayments may not repeat at the same magnitude.
• Analyst reactions cited in the press reflect third-party interpretation, not audited fact.

Where to view in the explorer

• JBSS3 — JBS N.V.
• Company list
• Blog

Sources

• JBS N.V. 2Q26 earnings release (Globe Newswire / IR), 10/08/2026 — net sales, EBITDA, segment data, leverage, FCF, non-recurring items
• JBS 2Q26 earnings conference call transcript, August 2026 — finance expenses, working-capital commentary, China quota outlook
• Folha de S.Paulo / Reuters, 11/08/2026 — net loss, US beef margin, Pilgrim's decline, antitrust and bond-tender charges
• BPMoney, 10/08/2026 — consolidated figures, segment EBITDA, consensus comparison
• Eu Quero Investir, 11/08/2026 — ~4% stock drop, leverage at 3.1x, analyst commentary (XP, Genial, UBS)
• BeefPoint, 11/08/2026 — first loss after eleven profitable quarters, Brazil record EBITDA
• JBSS3 on the explorer — filings and quote

Disclaimer

This article is for informational and educational purposes only. It is not investment advice. Adjusted figures differ from reported GAAP/IFRS results, and net income can be affected by non-operating items that do not repeat. JBS operates across multiple geographies and accounting presentations; when in doubt, the official CVM filings and JBS IR materials prevail. Refer to those documents and, if needed, a licensed professional.